12/3/2010

J.B. Chemicals & Pharmaceuticals has obtained FDA approval to launch 25- and 50-milligram tablets of anti-inflammatory drug diclofenac sodium. The generic-drug maker already sells the treatment in 75-milligram strength.

Related Summaries